-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The ICH guiding principle "S12: Research on the Biodistribution of Gene Therapy Products" is now in the third stage for comments
.
In accordance with the requirements of the relevant ICH regulations, the members of the ICH regulatory body need to collect opinions from the region on the draft guidelines for stage 2b and feed back to ICH
See the attachment for the original text and translation of the S12 draft.
If you have any comments from all walks of life, please give feedback to our center via email before October 15, 2021
Contact: Ye Xuan
Email: yex@cde.
annex:
1.
2.
ICH work office
July 13, 2021
Attachment 1: [English] ICH_S12_Step2_DraftGuideline.
[English] ICH_S12_Step2_DraftGuideline.
[Chinese] Non-clinical biodistribution considerations of S12 gene therapy products (Step3).